CVKD vs IRM · $20.2M cap vs P/E 136, rev $3.97B
Cadrenal Therapeutics, Inc. Common Stock (CVKD) versus Iron Mountain Incorporated (IRM) — a side-by-side from cached financials, not a winner call.
Cadrenal Therapeutics, Inc. Common Stock (CVKD) is a biotechnology company listed on US.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
CVKD does not have a complete income-statement cache yet.
Latest reported IRM revenue for 2026-06-30 was $3.97B. Net income was $255.1M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
CVKD currently screens at market cap $20.2M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Not investment advice. Open the CVKD and IRM stock pages for the full models.
Not investment advice.